These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25126810)

  • 41. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
    Nutman A; Glick R; Temkin E; Hoshen M; Edgar R; Braun T; Carmeli Y
    Clin Microbiol Infect; 2014 Dec; 20(12):O1028-34. PubMed ID: 24930471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.
    Lee NY; Lee HC; Ko NY; Chang CM; Shih HI; Wu CJ; Ko WC
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):713-9. PubMed ID: 17520546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Investigation of Carbapenem-Resistant Acinetobacter spp. from Hospitals in North Rhine-Westphalia, Germany.
    Rieber H; Frontzek A; Pfeifer Y
    Microb Drug Resist; 2017 Jan; 23(1):25-31. PubMed ID: 27093111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clonal complexes 104, 109 and 113 playing a major role in the dissemination of OXA-carbapenemase-producing Acinetobacter baumannii in Southeast Brazil.
    Clímaco EC; Oliveira ML; Pitondo-Silva A; Oliveira MG; Medeiros M; Lincopan N; da Costa Darini AL
    Infect Genet Evol; 2013 Oct; 19():127-33. PubMed ID: 23838284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mortality associated with Acinetobacter baumannii complex bacteremia among patients with war-related trauma.
    Kang G; Hartzell JD; Howard R; Wood-Morris RN; Johnson MD; Fraser S; Weintrob A; Wortmann G
    Infect Control Hosp Epidemiol; 2010 Jan; 31(1):92-4. PubMed ID: 19929690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study.
    Chaari A; Pham T; Mnif B; Chtara K; Medhioub F; Baccouche N; Bahloul M; Hammami A; Bouaziz M
    Intensive Care Med; 2015 Nov; 41(11):2018-9. PubMed ID: 26264246
    [No Abstract]   [Full Text] [Related]  

  • 47. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt.
    Al-Agamy MH; Khalaf NG; Tawfick MM; Shibl AM; El Kholy A
    Int J Infect Dis; 2014 May; 22():49-54. PubMed ID: 24607428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of OXA-23 and OXA-58 Carbapenemases Coexpressed in Clinical Isolates of Acinetobacter baumannii in Tunisia.
    Mathlouthi N; Ben Lamine Y; Somai R; Bouhalila-Besbes S; Bakour S; Rolain JM; Chouchani C
    Microb Drug Resist; 2018 Mar; 24(2):136-141. PubMed ID: 28691891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Singkham-In U; Chatsuwan T
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):169-174. PubMed ID: 29433997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Preliminary investigation of the molecular mechanisms of imipenem-resistance in clinical isolates of Acinetobacter baumannii in Xi'an].
    Tan XS; Liu Y; Han XP
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1393-6. PubMed ID: 19620063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reducing risk of waterborne imipenem-resistant Acinetobacter baumannii.
    Cervia JS
    Pediatr Infect Dis J; 2013 Jan; 32(1):97-8. PubMed ID: 23241997
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical and epidemiological characterization of infections due to imipenem resistant Acinetobacter baumannii at the university hospital Sahloul, Tunisia].
    Mansour W; Bouallegue O; Jeday S; Naïja W; Boujaafar N
    Ann Biol Clin (Paris); 2007; 65(6):593-9. PubMed ID: 18039603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reply: Reducing risk of waterborne imipenem-resistant Acinetobacter baumannii.
    Choi EH; Lee HJ; Hong KB
    Pediatr Infect Dis J; 2013 Jan; 32(1):98. PubMed ID: 23241998
    [No Abstract]   [Full Text] [Related]  

  • 55. Empirical antimicrobial therapy for critically ill patients with Acinetobacter baumannii bacteremia: combination is better.
    Lee NY; Lee JC; Li MC; Li CW; Ko WC
    J Microbiol Immunol Infect; 2013 Oct; 46(5):397-8. PubMed ID: 23632604
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex.
    Huang YS; Wang JT; Sheng WH; Chuang YC; Chang SC
    J Microbiol Immunol Infect; 2015 Oct; 48(5):545-51. PubMed ID: 24662017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea.
    Jeong SH; Bae IK; Park KO; An YJ; Sohn SG; Jang SJ; Sung KH; Yang KS; Lee K; Young D; Lee SH
    J Microbiol; 2006 Aug; 44(4):423-31. PubMed ID: 16953178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spread of imipenem-resistant Acinetobacter baumannii of European clone II in Western China.
    He C; Xie Y; Fan H; Kang M; Tao C; Zhang R; Hu Y; Chen Z; Wang L
    Int J Antimicrob Agents; 2011 Sep; 38(3):257-60. PubMed ID: 21705198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variations of CHROMagar Acinetobacter to detect imipenem-resistant Acinetobacter baumannii-calcoaceticus complex.
    Barsoumian A; Calvano T; Markelz AE; Cassidy R; Murray CK; Beckius ML; Mende K; Akers KS
    Scand J Infect Dis; 2013 Jun; 45(6):446-52. PubMed ID: 23317168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.